Volume Alert - GERN 3.07 Geron Corp $GERN Hit a high today of 3.08 Closing the day 10:30 at 3.07 +0.31 +11.23% With a day low of 2.74 and a total volume of 5,826,656.
GERN Recent Posts: http://investorshangout.com/Geron-Corporation-GERN-54220/
GERN Geron Corp Recent Headline News
J&J deal stokes Geron
Seeking Alpha - at Seeking Alpha - 27 mins ago
GERN: 3.03 (+0.27)
Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal
at The Street - 29 mins ago
Shares of Geron (GERN) soared in morning trading Monday after the company announced late last week it had licensed its blood disorder drug imetelstat to Johnson & Johnson JNJ.
GERN: 3.03 (+0.27)
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 44 mins ago
Geron (GERN) was a big mover last session, with shares surging over 19% on the day.
BIIB: 306.68 (+1.25), GERN: 3.03 (+0.27), ILMN: 181.18 (+0.68), AFFX: 9.36 (-0.35)
Nasdaq stocks posting largest volume increases
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NVEE: 12.01 (+1.52), GERN: 3.03 (+0.27), RDI: 11.93 (-0.06), RDIB: 12.00 (-0.04)
Most active Nasdaq-traded stocks
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.10 (-0.96), GERN: 3.03 (+0.27), ARCP: 8.74 (+0.01), MSFT: 49.32 (-0.26), AAPL: 114.49 (+0.31), CSCO: 26.09 (-0.23)
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 306.68 (+1.25), JNJ: 108.28 (+0.12), GERN: 3.03 (+0.27), AFFX: 9.36 (-0.35)
Geron Set to Possibly Pullback After Yesterday's Rally of 19.48%
Comtex SmarTrend(R) - Fri Nov 14, 4:49PM CST
Geron (NASDAQ:GERN) traded in a range yesterday that spanned from a low of $2.72 to a high of $3.33. Yesterday, the shares gained 19.5%, which took the trading range above the 3-day high of $2.44 on volume of 31.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GERN: 3.03 (+0.27)
Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 38.95 (-0.85), AMZN: 320.59 (-7.23), JNJ: 108.28 (+0.12), HTZ: 21.99 (+0.30), GERN: 3.04 (+0.28), HAL: 50.85 (-4.23), JWN: 73.47 (-0.70), NOK: 7.68 (-0.18), BHI: 67.07 (+7.18)
Geron to Present at the Stifel Healthcare Conference
Thomson Reuters ONE - Fri Nov 14, 3:15PM CST
MENLO PARK, Calif., November 14, 2014 - Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the Stifel 2014 Healthcare Conference in New York. The presentation is scheduled to occur on Wednesday, November 19th at 1:50 p.m. Eastern Time.
GERN: 3.04 (+0.28)
Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.28 (+0.12), GERN: 3.04 (+0.28)
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 38.95 (-0.85), JNJ: 108.28 (+0.12), HTZ: 21.99 (+0.30), VA: 30.63 (+0.63), GERN: 3.04 (+0.28), JWN: 73.46 (-0.71)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:46AM CST
ZIOP: 3.73 (unch), BSPM: 1.36 (-0.03), BDR: 1.68 (-0.09), ZAZA: 3.18 (unch), ACY: 8.05 (-0.45), NBS: 6.94 (+0.77), SYRX: 1.37 (-0.06), IAG: 2.14 (+0.02), THTI: 1.39 (-0.02), BITA: 89.28 (-2.63), VRTB: 4.80 (-0.18), OPTT: 1.12 (-0.05), INVT: 0.78 (-0.12), GERN: 3.04 (+0.28), VASC: 23.47 (-0.27), LOCM: 1.46 (+0.06), CTHR: 1.83 (+0.05), MOV: 25.82 (-0.43), IFON: 1.26 (-0.15), SVM: 1.43 (+0.06)
Traders Get Bullish on Shares of Geron, Shares Up 28.6% (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 10:07AM CST
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 28.6% to $2.97 on 5.5x average daily volume. Geron has traded 17.8 million shares thus far today, vs. average volume of 3.2 million shares per day. The stock has outperformed the Dow (28.6% to the Dow's -0.0%) and outperformed the S&P 500 (28.6% to the S&P's 0.1%) during today's trading.
GERN: 3.04 (+0.28)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:13AM CST
BDR: 1.68 (-0.09), GERN: 3.04 (+0.28), TUBE: 15.50 (-1.45), WYY: 1.48 (+0.03), YOD: 2.11 (-0.09), DGLY: 12.00 (+0.50), PBYI: 222.81 (+6.59), ENLK: 28.28 (-0.09), BHI: 67.05 (+7.16), SVM: 1.43 (+0.06)
Upgrade Alert for Geron (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 7:57AM CST
Geron (NASDAQ:GERN) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $2.31 on volume of 2.5 million shares, below average daily volume of 3.2 million. Geron share prices have moved between a 52-week high of $7.79 and a 52-week low of $0.91 and closed yesterday at 154% above that low price at $2.31 per share. Over the past week, the 200-day moving average (MA) has gone down 1.8% while the 50-day MA has declined 0.4%.
GERN: 3.04 (+0.28)
Geron up big premarket on J&J deal
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 7:55AM CST
GERN: 3.04 (+0.28)
Geron wins deal to develop blood disorder drug, could get $935M
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 4:55PM CST
JNJ: 108.28 (+0.12), GERN: 3.04 (+0.28)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 4:37PM CST
TSE: 14.21 (+0.52), WB: 18.72 (-0.21), VJET: 12.88 (-0.01), ALDW: 17.56 (+0.43), FRSH: 9.00 (-0.10), GERN: 3.04 (+0.28), TUBE: 15.50 (-1.45), XON: 25.11 (+1.65), RTRX: 9.39 (-0.51), PBYI: 222.81 (+6.59)
Geron could get $935M in blood disorder drug deal
AP - Thu Nov 13, 4:06PM CST
NEW YORK (AP) — Geron Corp. said Thursday it could get more than $900 million from a deal to develop its blood disorder drug imetelstat with a unit of Johnson & Johnson.
JNJ: 108.28 (+0.12), GERN: 3.04 (+0.28)
GERN Recent Posts: http://investorshangout.com/Geron-Corporation-GERN-54220/
GERN Geron Corp Recent Headline News
J&J deal stokes Geron
Seeking Alpha - at Seeking Alpha - 27 mins ago
GERN: 3.03 (+0.27)
Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal
at The Street - 29 mins ago
Shares of Geron (GERN) soared in morning trading Monday after the company announced late last week it had licensed its blood disorder drug imetelstat to Johnson & Johnson JNJ.
GERN: 3.03 (+0.27)
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 44 mins ago
Geron (GERN) was a big mover last session, with shares surging over 19% on the day.
BIIB: 306.68 (+1.25), GERN: 3.03 (+0.27), ILMN: 181.18 (+0.68), AFFX: 9.36 (-0.35)
Nasdaq stocks posting largest volume increases
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NVEE: 12.01 (+1.52), GERN: 3.03 (+0.27), RDI: 11.93 (-0.06), RDIB: 12.00 (-0.04)
Most active Nasdaq-traded stocks
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.10 (-0.96), GERN: 3.03 (+0.27), ARCP: 8.74 (+0.01), MSFT: 49.32 (-0.26), AAPL: 114.49 (+0.31), CSCO: 26.09 (-0.23)
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 306.68 (+1.25), JNJ: 108.28 (+0.12), GERN: 3.03 (+0.27), AFFX: 9.36 (-0.35)
Geron Set to Possibly Pullback After Yesterday's Rally of 19.48%
Comtex SmarTrend(R) - Fri Nov 14, 4:49PM CST
Geron (NASDAQ:GERN) traded in a range yesterday that spanned from a low of $2.72 to a high of $3.33. Yesterday, the shares gained 19.5%, which took the trading range above the 3-day high of $2.44 on volume of 31.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GERN: 3.03 (+0.27)
Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 38.95 (-0.85), AMZN: 320.59 (-7.23), JNJ: 108.28 (+0.12), HTZ: 21.99 (+0.30), GERN: 3.04 (+0.28), HAL: 50.85 (-4.23), JWN: 73.47 (-0.70), NOK: 7.68 (-0.18), BHI: 67.07 (+7.18)
Geron to Present at the Stifel Healthcare Conference
Thomson Reuters ONE - Fri Nov 14, 3:15PM CST
MENLO PARK, Calif., November 14, 2014 - Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the Stifel 2014 Healthcare Conference in New York. The presentation is scheduled to occur on Wednesday, November 19th at 1:50 p.m. Eastern Time.
GERN: 3.04 (+0.28)
Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.28 (+0.12), GERN: 3.04 (+0.28)
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 38.95 (-0.85), JNJ: 108.28 (+0.12), HTZ: 21.99 (+0.30), VA: 30.63 (+0.63), GERN: 3.04 (+0.28), JWN: 73.46 (-0.71)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:46AM CST
ZIOP: 3.73 (unch), BSPM: 1.36 (-0.03), BDR: 1.68 (-0.09), ZAZA: 3.18 (unch), ACY: 8.05 (-0.45), NBS: 6.94 (+0.77), SYRX: 1.37 (-0.06), IAG: 2.14 (+0.02), THTI: 1.39 (-0.02), BITA: 89.28 (-2.63), VRTB: 4.80 (-0.18), OPTT: 1.12 (-0.05), INVT: 0.78 (-0.12), GERN: 3.04 (+0.28), VASC: 23.47 (-0.27), LOCM: 1.46 (+0.06), CTHR: 1.83 (+0.05), MOV: 25.82 (-0.43), IFON: 1.26 (-0.15), SVM: 1.43 (+0.06)
Traders Get Bullish on Shares of Geron, Shares Up 28.6% (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 10:07AM CST
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 28.6% to $2.97 on 5.5x average daily volume. Geron has traded 17.8 million shares thus far today, vs. average volume of 3.2 million shares per day. The stock has outperformed the Dow (28.6% to the Dow's -0.0%) and outperformed the S&P 500 (28.6% to the S&P's 0.1%) during today's trading.
GERN: 3.04 (+0.28)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:13AM CST
BDR: 1.68 (-0.09), GERN: 3.04 (+0.28), TUBE: 15.50 (-1.45), WYY: 1.48 (+0.03), YOD: 2.11 (-0.09), DGLY: 12.00 (+0.50), PBYI: 222.81 (+6.59), ENLK: 28.28 (-0.09), BHI: 67.05 (+7.16), SVM: 1.43 (+0.06)
Upgrade Alert for Geron (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 7:57AM CST
Geron (NASDAQ:GERN) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $2.31 on volume of 2.5 million shares, below average daily volume of 3.2 million. Geron share prices have moved between a 52-week high of $7.79 and a 52-week low of $0.91 and closed yesterday at 154% above that low price at $2.31 per share. Over the past week, the 200-day moving average (MA) has gone down 1.8% while the 50-day MA has declined 0.4%.
GERN: 3.04 (+0.28)
Geron up big premarket on J&J deal
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 7:55AM CST
GERN: 3.04 (+0.28)
Geron wins deal to develop blood disorder drug, could get $935M
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 4:55PM CST
JNJ: 108.28 (+0.12), GERN: 3.04 (+0.28)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 4:37PM CST
TSE: 14.21 (+0.52), WB: 18.72 (-0.21), VJET: 12.88 (-0.01), ALDW: 17.56 (+0.43), FRSH: 9.00 (-0.10), GERN: 3.04 (+0.28), TUBE: 15.50 (-1.45), XON: 25.11 (+1.65), RTRX: 9.39 (-0.51), PBYI: 222.81 (+6.59)
Geron could get $935M in blood disorder drug deal
AP - Thu Nov 13, 4:06PM CST
NEW YORK (AP) — Geron Corp. said Thursday it could get more than $900 million from a deal to develop its blood disorder drug imetelstat with a unit of Johnson & Johnson.
JNJ: 108.28 (+0.12), GERN: 3.04 (+0.28)
